Agilent Technologies, Inc. $A Shares Sold by Brown Shipley& Co Ltd

Brown Shipley& Co Ltd decreased its holdings in Agilent Technologies, Inc. (NYSE:A) by 53.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 9,869 shares of the medical research company’s stock after selling 11,343 shares during the quarter. Agilent Technologies makes up 0.7% of Brown Shipley& Co Ltd’s portfolio, making the stock its 23rd biggest position. Brown Shipley& Co Ltd’s holdings in Agilent Technologies were worth $1,343,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. Wellington Management Group LLP lifted its stake in shares of Agilent Technologies by 4.8% in the third quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock worth $1,203,990,000 after acquiring an additional 433,342 shares in the last quarter. Generation Investment Management LLP lifted its stake in shares of Agilent Technologies by 10.1% in the third quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock worth $816,043,000 after acquiring an additional 582,093 shares in the last quarter. Ameriprise Financial Inc. lifted its stake in shares of Agilent Technologies by 15.1% in the third quarter. Ameriprise Financial Inc. now owns 2,708,591 shares of the medical research company’s stock worth $347,685,000 after acquiring an additional 354,480 shares in the last quarter. Troy Asset Management Ltd lifted its stake in shares of Agilent Technologies by 0.3% in the third quarter. Troy Asset Management Ltd now owns 2,404,161 shares of the medical research company’s stock worth $308,574,000 after acquiring an additional 6,341 shares in the last quarter. Finally, Legal & General Group Plc lifted its stake in shares of Agilent Technologies by 0.9% in the third quarter. Legal & General Group Plc now owns 2,189,639 shares of the medical research company’s stock worth $281,040,000 after acquiring an additional 19,874 shares in the last quarter.

Agilent Technologies Trading Down 0.5%

Shares of NYSE A opened at $114.94 on Tuesday. The stock’s 50 day moving average price is $120.86 and its two-hundred day moving average price is $134.45. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $160.27. The stock has a market capitalization of $32.48 billion, a P/E ratio of 25.37, a PEG ratio of 2.43 and a beta of 1.30. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). The company had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.81 billion. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio is presently 22.52%.

Analysts Set New Price Targets

Several research analysts recently commented on A shares. Wells Fargo & Company cut their price target on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research note on Thursday, February 26th. The Goldman Sachs Group initiated coverage on Agilent Technologies in a research note on Tuesday, December 9th. They set a “buy” rating and a $170.00 price objective on the stock. Morgan Stanley cut their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. TD Cowen cut their price objective on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Finally, Evercore upgraded Agilent Technologies from an “in-line” rating to an “outperform” rating and upped their price objective for the company from $155.00 to $160.00 in a research note on Monday, January 5th. Two research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $161.20.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.